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Abstract We report the detailed expression pattern of the
voltage-dependent potassium channel KV3.4 (rat homologue,
Raw3) in mouse skeletal muscle. Using semi-quantitative RT-
PCR, we show that its expression is detectable at embryonic day
17 and rises to adult levels within 2 weeks after birth. Expression
is fiber type-dependent, with mRNA levels being 5^6-fold lower
in the mixed slow/fast soleus muscle than in the fast tibialis
anterior and extensor digitorum longus muscles. Fast muscles
from myotonic mice exhibit low KV3.4 mRNA levels similar to
those of wild-type soleus. In denervated extensor digitorum
longus, KV3.4 expression declines to perinatal levels. We
conclude that KV3.4 expression in mouse skeletal muscle is
regulated by the pattern of excitation.
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1. Introduction
In mammalian skeletal muscle, many genes drastically
change their expression level during development and matu-
ration, and respond to innervation and denervation. For ex-
ample, genes for the myogenic factors MyoD, myogenin and
myf-5 and for acetylcholine receptor subunits are down-regu-
lated during synapse formation and up-regulated after surgi-
cal or physiological denervation [1,2]. In contrast, the genes
for the Ca2-binding protein parvalbumin (Pva) and for the
muscular chloride channel 1 (ClC-1), which are highly ex-
pressed in mature fast-twitch muscle ¢bers, are down-regu-
lated after denervation [2^4].
Neurogenic and muscle intrinsic factors interact during
muscle development in order to establish and maintain the
individual functional pro¢les of skeletal muscle ¢ber types
and adapt it to changing conditions [5]. Expression of a
slow phenotype is dependent on a tonic stimulation pattern
[6,7], whereas the fast myo¢brillar phenotype is to be consid-
ered the ‘default program’, which occurs even in the absence
of innervation [8]. In the adult, neural activity plays an im-
portant role in the maintenance and plasticity of ¢ber type-
speci¢c pro¢les.
The myotonic mouse mutant ADR and its allelic forms are
characterized by hyperexcitability due to the absence of a
functional Clc1 gene product [9,10]. As a consequence of re-
petitive action potentials and after-discharges of the sarcolem-
ma, the ¢ber type pro¢le is shifted towards fast-oxidative IIA
[11,12], comparable to the changes after chronic stimulation
(cf. [5]).
The voltage-gated potassium channel KV3.4 (gene symbol:
Kcnc4 ; chromosome 3 [13]) is a fast-inactivating member of
the Shaw subfamily of shaker-type potassium channels [14].
Unlike other members of this subfamily, which are almost
exclusively expressed in the central nervous system, KV3.4
mRNA is found mainly in skeletal muscle [15], where it might
be involved in the modulation of Ca2 inward currents [14].
Here we report the detailed expression pattern of KV3.4 in
mouse skeletal muscle with respect to development, ¢ber type
distribution and pathological activity patterns as found in the
disease myotonia and after denervation.
2. Materials and methods
2.1. Animals and tissues
A2G and C57BL/6 wild-type and myotonic BALB/c mice carrying
the Clc1adrÿmto2J allele [16] were used as a source of skeletal muscle
RNA (M. extensor digitorum longus, EDL, M. tibialis anterior, TA
and M. soleus); neonatal skeletal muscle RNAs were from total hind-
limb muscles of 1^10 days old wild-type mice; embryonic RNA was
from skinned total hindlimbs. Muscles from a minimum of three mice
were pooled for each individual mRNA preparation.
2.2. Cell culture
M12 myogenic cells [17] were cultured as described [18]. Myotubes
were harvested 4 days after induction of myoblast fusion.
2.3. Denervation experiments
Lower hindlimb muscles of wild-type mice were denervated by
transection of the N. ischiadicus. Experiments were performed accord-
ing to the German law for the protection of animals with an approved
permit from the local authorities.
2.4. Reverse transcription and PCR
Total RNA from cells and tissues was puri¢ed according to Chom-
czynski and Sacchi [19]. 1 Wg of total RNA in 20 Wl reaction volume
was subjected to reverse transcription (RT) according to Kawasaki
[20] using 200 U MMLV reverse transcriptase (SuperScript, Life
Technologies GmbH, Eggenstein, Germany). 1 Wl RT was used for
20 Wl duplex PCRs co-amplifying KV3.4 and L7 ribosomal protein
cDNA as an internal standard [21]. The KV3.4 primers we used were
derived from a partial genomic sequence [22]: KV3.4s (5P TGG GCT
GTG GTC ACC ATG AC-3P) and KV3.4a (5P-CTC TCG ACC ACA
CCC TCT TCC-3P) ; L7 primers: L7s (5P-AGA TGT ACC GCA CTG
AGA TTC-3P) and L7as (5P-ACT TAC CAA GAG ACC GAG
CAA-3P). PCR was performed on a Trio-Thermoblock (Biometra,
Goºttingen, Germany) using AmpliTaq polymerase (Perkin Elmer,
Uº berlingen, Germany) and 0.5 WM of each primer under the following
conditions: 4 min initial denaturation at 94‡C, 10 cycles with 30 s
denaturation at 92‡C, 1 min annealing at 62‡C and 30 s elongation at
72‡C, seven cycles with the same parameter except for an additional
10 s stepwise increment of elongation time and ¢nally a 5 min
last extension step. For control experiments, a total number of 24
ampli¢cation cycles were run. The PCR products were separated on
a 1.5% TBE agarose gel and visualized by ethidium bromide stain-
ing.
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2.5. Slot blot hybridization and quantitation
Ampli¢cation products were heat-denatured for 10 min and subse-
quently cooled on ice. After addition of 20USSC to a ¢nal volume of
500 Wl, PCR samples were immediately applied to a Minifold II Slot
Blotter (Schleicher und Schuº ll, Dassel, Germany) using Nylonbind B
membrane (Serva, Heidelberg, Germany). One series was probed with
a 32P-labeled 576 bp HindIII-EcoRV fragment of rat Raw3-cDNA (nt
1861^2437), another was hybridized with the L7 PCR product de-
scribed above. After stringent washing in 0.1USSC for 15 min at
65‡C, membranes were autoradiographed. For quantitation, slot
dots were cut out of the membrane and subjected to liquid scintilla-
tion counting using a TriCarb 300 (Packard-Canberra, Frankfurt/M.,
Germany).
3. Results and discussion
Although in rodents KV3.4 expression is highest in skeletal
muscle, absolute mRNA concentrations are low and therefore
di⁄cult to demonstrate by Northern blot analysis. To over-
come this limitation, we have developed a semi-quantitative
duplex RT-PCR, amplifying a 322 bp fragment from an in-
ternal exon of the murine KV3.4 gene together with a 352 bp
fragment of the small ribosomal protein L7. The L7 mRNA
served as an internal standard, as its level is not a¡ected by
the physiological and pathological conditions investigated in
this work (Fig. 1).
KV3.4 expression is low but detectable in hindlimb muscles
of the 17dE mouse embryo and rises postnatally within about
2 weeks to the adult level (Fig. 2). In cultured myoblasts and
myotubes, virtually no KV3.4 mRNA could be demonstrated.
Thus KV3.4 expression is up-regulated late during muscle
ontogeny and parallels the maturation of muscle ¢bers.
We further investigated whether KV3.4 mRNA is di¡eren-
tially expressed with respect to ¢ber type composition. KV3.4
is highly expressed in the mixed glycolytic-oxidative fast EDL
and TA muscles, which are composed mainly of IIB and IID/
X ¢bers [23]. The mixed slow-fast soleus muscle, which is
composed of type I slow oxidative and type IIA fast oxida-
tive-glycolytic ¢bers, showed 5^6-fold lower expression levels
(Fig. 3). A similar result has been found by Northern blotting
on rat EDL and soleus muscles [24].
To elucidate the in£uence of activity pattern of the skeletal
muscle ¢ber on KV3.4 expression, mRNA levels of EDL, TA
and soleus muscles from the myotonic mouse mutant ADR
were determined. Expression of KV3.4 in the myotonic EDL
is greatly reduced and comparable to that of the wild-type
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Fig. 1. Duplex RT-PCR to determine KV3.4 mRNA levels in mouse. a: Samples from adult skeletal muscle and brain separated on a 1.5%
TBE agarose gel. The cDNA of the rat KV3.4 homologue Raw3 served as a positive control for KV3.4 PCR, RNA without reverse transcrip-
tion was used to test for the ampli¢cation of genomic background in RNA samples. This genomic contamination was below 1% of the total
PCR product, as calculated from the ratio of corresponding radioactive hybridization signals of non-reverse transcribed to those of cDNA-con-
verted samples (data not shown). However, all quantitated data were corrected for genomic background ampli¢cation. b: Increment of KV3.4
and L7 RT-PCR products from murine adult skeletal muscle RNA with total cycle number. Quantitation was done by liquid scintillation
counting of radioactive hybridization. Values are given as binary logarithms of counts per minute. From these data, 18 cycles were chosen for
subsequent experiments to ensure maximal sensitivity and linearity of the PCR reaction.
Fig. 2. Expression of KV3.4 during mouse muscle development.
Myoblasts and myotubes were from the secondary mouse myogenic
cell strain M12. Embryonic total RNA was puri¢ed from total
skinned hindlimbs. RNAs were prepared from lower hindlimb
muscles of mice of the indicated ages. KV3.4 mRNA levels were
quantitated as described in Fig. 1b and normalized for the expres-
sion of the ribosomal protein L7. Values are given as percentage of
L7 hybridization signal.
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soleus, whereas the myotonic soleus remains essentially unaf-
fected (Fig. 3). This secondary reduction of KV3.4 expression
in the myotonic mouse is restricted to skeletal muscle, as
mRNA levels in the CNS of mutant mice were not reduced
(data not shown). These data suggest a strong in£uence of the
muscular activity pattern on KV3.4 mRNA levels, most likely
on transcription.
To test whether motoneural activity is necessary for expres-
sion, the e¡ect of denervation on fast and mixed slow-fast
twitch muscles was investigated. KV3.4 expression was re-
duced in denervated EDL and TA, but slightly elevated in
the soleus. Possibly the tonic excitation pattern of the soleus
muscle suppresses KV3.4 expression.
Table 1 summarizes the data of KV3.4 expression in skel-
etal muscle of rodents and compares them to those of the
muscular chloride channel ClC-1 and the Ca2-binding pro-
tein parvalbumin. These messages have in common that they
are not signi¢cantly expressed in myotubes, and are up-regu-
lated perinatally during the process of innervation. Highest
expression levels correlate with the abundance of glycolytic
fast-twitch ¢bers [4,25]. All three genes are down-regulated
in the denervated muscle, which suggests that innervation is
the major stimulus of expression during maturation. The
pathological condition myotonia leads to a down-regulation
of KV3.4 mRNA levels in fast-twitch muscles like TA and
EDL, as was shown for parvalbumin [26]. However, regula-
tion of ClC-1 expression in myotonic muscles di¡ers from that
of KV3.4 and parvalbumin mRNAs (Table 1). Comparison of
the promoter regions of these genes may help to delineate the
cis- and trans-acting regulatory elements, or modules of them
[27], which are responsible for the expression of maturation-
and activity-dependent genes in the skeletal muscle.
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Fig. 3. Role of excitability and innervation on KV3.4 expression in
murine fast and mixed fast-slow twitch muscles. KV3.4 mRNA lev-
els in muscles of the myotonic mouse mutant ADR*2J and in de-
nervated wild-type muscles are compared to the corresponding un-
treated wild-type muscles. KV3.4 expression in surgically denervated
wild-type muscles was determined 7 days after transection. The ef-
fect of denervation was validated by Northern blot analysis of nico-
tinic acetylcholine receptor K subunit (nAChRK) expression, which
is steeply up-regulated upon denervation (data not shown). Quanti-
tation and normalization as in Fig. 2.
Table 1
Comparison of expression of three activity-regulated genes in mur-
ine skeletal muscle
KV3.4 ClC-1 Pva
Brain + [15] 0 [28] + [29]
Skeletal muscle (adult) + + [28] + [25]
Postnatal development 0 0 [30] 0 [3]
EDL/soleus 6 5 [4] 20 [4]
Myotonia
EDL s W [4] ss [4]
soleus W u [4] s [31]
Denervation
EDL s s [4] s [3]
Arrows pointing up, mRNA levels were increased compared to con-
trol wild-type; arrows pointing down, mRNA levels were decreased.
Factors: two arrows, s 20-fold, one arrow, 2^20-fold, W, no signi¢-
cant increase. KV3.4 and Pva mRNA levels were not changed in the
brain of myotonic mice [26].
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